Summary.-The level of Gross cell-surface antigen (GCSAa) expression at the surface of murine retrovirus-infected fibroblasts was determined by quantitative absorption of the anti-GCSAa activity of a serum produced in syngeneic W/Fu rats immunized against (C58NT)D lymphoma, and tested in a cytotoxicity assay against ESG2 lymphoma cells.
ESG2 lymphoma cells.
While GCSAa was specifically expressed on Gross-type virus (G-MuLV)-induced lymphoma cells, and while G-MuLV and G-related MuLV induced a high level of GCSAa expression on murine fibroblasts, the Friend-Moloney-Rauscher (FMR) group viruses (FMR MuLV) and xenotropic isolates were also able to induce a high or intermediate level of GCSAa. Since GCSAa has been shown to be borne by glycosylated precursors of the viral nucleocapside (gp95gag and gp85gag), the amount of GCSAa expressed on these cells was compared to the level of cytoplasmic p30. In G-and G-related MuLV-infected cell lines, a significant relationship was found between the amount of GCSAa and the level of p30, whereas in FMR-MuLV or xenotropic virus-infected cells the amount of GCSAa varied independently of the p30 level. These results could explain the discrepancy in the specificity of expression of GCSAa in vivo and in vitro.
RETROVIRUS-IND UCED) TUMOURS bear
specific virus-induced surface antigens which could act as targets in the immunological control of the tumour (Bauer, 1974) . Thus, lymphomas induced by the Gross murine leukaemia virus (G-MuLV) express the Gross cell surface antigen (GCSA) which is specific for this MuLV and is not expressed on lymphomas induced by MuLV of the Friend-MoloneyRauscher (FMR) group (Old et al., 1965; Geering et al., 1966) . The specificity of GCSA expression can however be questioned in studies of in vitro cultured cells, since in vitro infection of fibroblasts by FMR-MuLV can result in GCSA expression (O'Donnel & Stockert, 1976) . Therefore it could be asked whether in vitro infections by G-MuLV or FMR-MuLV result in a quantitative rather than qualitative difference in GCSA expression. Since GCSA has been demonstrated to be glycosylated precursors of gag virus proteins (Ledbetter & Nowinski, 1977; Snyder et al., 1977) the comparison of the expression of this cell-surface antigen with the intracellular viral nucleocapside proteins could provide a further insight into the gag gene expression during infection by G-and FMR-MuLV. A specific determination of the level of GCSA expression was therefore developed, using quantitative absorption of the antiGCSAa activity of a W/Fu rat antiserum defined by a cytotoxicity assay on E,G2 lymphoma target cells (Geering et al., 1966 , Herberman et al., 1972 . GCSAa induction by ecotropic G-MuLV or FMRMuLV and xenotropic murine retroviruses was measured in relation to the level of cytoplasmic viral nucleocapside p30 in the same cells.
MATERIAL AND METHODS
Animals and tumours.-The Gross virusinduced lymphoma (C58NT)D (Geering et al., 1966) was maintained in ascitic form by weekly transplantation in weanling syngeneic W/Fu/Ico rats. The G-MuLV-induced lymphoma ESG2 (Old et al., 1965) , R-MuLVinduced lymphoma RBL5 (McCoy et al., 1967) , Graffi-virus (Gi-MuLV)-induced lymphoma GiL4 (Levy et al., 1968) and benzo(a)-pyrene-induced lymphoma EL4 (Gorer, 1950) were maintained in syngeneic C57BL/6/Ico mice. Ico animals were purchased from IFFA-CREDO (France). 129/Sv/Cp mice were kindly provided by J. L. Guenet (Institut Pasteur, Paris).
Antiserum.-Antiserum to the (C58NT)D tumour was produced in a syngeneic W/Fu rat by s.c. inoculation of 4 x 108 viable tumour cells followed 4 weeks later by 5 booster injections of 2.108 viable tumour cells (Gerlier et al., 1977a) .
Cell lines and viruses.-Various tissuecultured cells of murine and non-murine origin were maintained in RPMI 1629 medium supplemented with 10% foetal calf serum, 100 u/ml of penicillin and 50 /g/ml of streptomycin. Details of the lines and viruses studied are given in Table I (Gerlier et al., 1977b) .
Results are expressed as the percentage of absorption (A) = C-T x 100, where C is the cytotoxicityindex of unabsorbed serum diluted 1: 150 and T the cytotoxicity index of absorbed serum. When A was plotted againstthe number of absorbing cells in a log/log scale, the relationship was found to be linear, as demonstrated by Dexter (1976) , and could be expressed by the following equation: log(A) =a log(N) + b where N is the number of absorbing cells, a the slope of the straight line and b a constant characteristic for each type of absorbing cell. Typical curve is shown in Fig. 1 MuLV p30 radioimmunoassay.-The major murine leukaemia virus internal protein, MuLV p30, was quantified by a competitive radioimmunoprecipitation assay, as previously described (Gisselbrecht et al., 1978) . A purified Rauscher p30 donated by Dr W. P. Parks (National Cancer Institute, Bethesda, Maryland) was iodinated by the chloramine T method (Greenwood et al., 1963) . Goat anti-xenotropic virus p30 serum was obtained from Dr Gruber (NCI, Bethesda). Rabbit antigoat y-globulin sera were prepared in our laboratory. The concentrations of cytoplasmic p30 in cultured cell lines were measured as follows: cells were harvested mechanically from culture flasks when monolayers had reached a subconfluent growth; after washing them in 0O01M Tris buffer (pH 7.5) 01M NaCl, cells were disrupted by brief ultrasonic treatment on ice. The resulting homogenates were centrifuged for 20 min at 3000 g and the supernatants stored at -70°C until used. Protein concentrations were assayed by the Lowry method. Homogenate supernatants used as competing Table  II (Herberman, 1972) , the GCSAa specificity of the serum used in these experiments was controlled in a cytotoxicity assay on E&G2 target cells. Data shown in Table III The GCSAa quantitative assay also yielded the degree of heterogeneity of the antibodies, which is characteristic for the antigen/antibody complex involved. This heterogeneity is expressed as the slope of the straight lines obtained when logs of the percentage of absorption are plotted against logs of the number of absorbing cells (Dexter, 1976) . The slopes of the absorption curves for E&G2 and We may therefore consider that the quantitative absorption test used in these experiments allowed a measurement of GCSAa at the surface of cultured cells. It should be stressed that this method, used to express the amount of GCSAa as the number of cells needed to absorb 50% of the anti-GCSAa activity (NA50) is highly reproducible, results were actually reproduced several times with a given cell and the same findings were also obtained with another anti-(C58NT)D serum (data not shown).
In vitro GCSAa expression induced by G-MuLV and G-related viruses
Since a large number of absorbing cells/,ul of serum could lead to unspecific absorption, we have chosen an NA50 of 5 x 105 cultured cells/1l as the upper limit of specific absorption. As indicated in I '.
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. tropic virus from Mus molossinus and C57 leaden mouse expressed GCSAa at a level equal to that of G-MuLV-infected mouse cell lines (Fig. 4 (Ledbetter & Nowinski, 1977; Snyder et al., 1977 , Tung et al., 1977 , the amount of intracellular p30 was determined 
DISCUSSION
Despite the presence of several antibody specificities, the anti-(C58NT)D W/Fu rat serum, when appropriately diluted and assayed on mouse ESG2 target cells, recognized mainly if not exclusively GCSAa, very few Gross-virus-induced lymphoma cells being needed to absorb out the cytotoxic activity, whereas RBL5 cells and 129 thymocytes, which defined the other G-related antigens GCSAb and GIx, could not absorb out this cytotoxic activity (Herberman, 1972) . Absorption of anti-GCSAa antibodies has however been observed with high numbers of leukaemic cells induced by other agents; this could be due to a nonspecific phenomenon, or to a slight expression of cross- reactive moieties on these cells (Herberman, 1972 (Fig. 1) , the straight lines obtained with FMRMuLV or xenotropic-virus-infected cells showed the same slope than those obtained with G-MuLV-infected cells (Table IV) . As hypothesized by Dexter (1976) , this was in favour of a homogeneous antigenantibody system involving the same affinity interactions. Anti-GCSAa antibodies being constant in our system, GCSAa determinant must be homogeneous on the various infected cultured cells. Furthermore, it is not unlikely that the GCSAa specificity we observed with the rat anti-(C58NT)D serum could represent the GCSA subspecificity common to G, FMR and xenotropic MuLV recognized by the C57BL/6 anti-AKR K36 lymphoma, mouse antiserum used in the abovementioned studies (O'Donnel & Stockert, 1976) . Thus, although the anti-GCSAa activity of the rat anti-(C58NT)D serum has been described as a G-MuLV typing serum when tested on lymphoma cells, it must be considered only as a MuLV- (Tung et al., 1977) . Although we had no direct evidence, it is not unlikely that, in this experiment, the GCSAa specificity detected by the anti-(C58NT)D serum, though MuLV-group specific, was borne by the gp95gag and gp85gag molecules, since the gp7O is also well expressed on the FMR-MuLV lymphomas cells (Bauer, 1974) . Moreover, the GCSA as defined by the mouse antiserum has been described to be borne also by gp85gag and gp95gag (Ledbetter & Nowinski 1977 , Snyder et al., 1977 . The discrepancy in specificity of the expression of GCSAa, which appears Gross-virus-specific on MuLVinduced leukaemias but nonspecific Gross virus on MuLV-infected fibroblasts, could be related to a weak or null expression of gp95gag or gp85gag on FMR-MuLV-induced lymphoma cells , while FMR-virus-infected fibroblasts could express them (Evans et al., 1977; Edwards & Fan 1979; Schultz et al., 1979; Buetti & Diggelman 1980) . In accordance with this hypothesis, FMRMuLV-induced lymphoma cells have been shown not to express p30 antigenic specificities at their surface (Humphrey et al., 1979; Nowinski et al., 1978; Schneider & Hunsmann, 1978) .
Antigenic sites associated with p30 molecules being at least partially involved in the GCSAa specificity (Ledbetter & Nowinski, 1977; Snyder et al., 1977) , it could be questioned whether the GCSAa expression is related to the level of intracellular nucleocapsid proteins, a reflection of the virus-cell metabolic interaction. A good relationship was found between the GCSAa level and the amount of intracellular p30 when the cells are infected with the G-type viruses, suggesting a homogeneous event. On the contrary no relationship was found during a FMR-MuLV or xenotropic virus infection. The absence of striking evidence for a relationship or independence, when cells were infected by xenotropic virus, would probably be due to the heterogeneity of xenotropic viruses (O'Donnel & Stockert 1976) . It is not unlikely that the absence of relationship between the amount of GCSAa and the p30 level in the case of FMR-MuLV infection was due to the MuLV group-specific determination of GCSAa and p30. This overall relationship could be very different from a relationship studied in MuLV-type specific conditions, if, for example, one of these products is the result of two different proviral expressions (one FMR and one endogeneous) as shown recently (Tung & Fleissner 1980) . However, this result can be compared with the recent findings that during FMR-MuLV infection the gag products expressed on the cell surface and the intracellular nucleocapsid proteins could result from two different metabolic pathways (Edwards & Fan, 1979; Ledbetter et al., 1978; Schultz et al., 1979) and, obviously, studies with MuLV-type-specific antisera and molecular determination of the antigen are needed.
These in vitro findings could explain the different antigenic specificity found between Gross and FMR virus-induced lymphomas, the gag precursor associated GCSA antigens persisting at the cell surface in the first case but not in FMR virus-induced tumours.
